Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation

Journal of Pathology

Volumn 190, Issue 2, 2000, Pages 184-189

  Jenkins, David ^a,b   Seth, Rashmi ^b   Kummer, J Alain ^c   Scott, Brian B ^d   Hawkey, Christopher J ^b   Robins, R Adrian ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d NONE

Author keywords

Apoptosis; Colitis; Crohn's disease; Cytokines; Cytotoxic; Inflammatory bowel diseases; T lymphocytes; Ulcerative

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GRANZYME B; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOTOXIC T LYMPHOCYTE; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TISSUE INJURY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; GENE EXPRESSION; GRANZYMES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033981007     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:2<184::AID-PATH531>3.0.CO;2-E     Document Type: Article

References (24)

1. Meenan D. An overview of the immunological basis of inflammatory bowel disease and its therapy. In Falk Symposium, Tytgaf GNJ, Bartelsman JFWM and van Deventer SJH (eds), vol 85. Kluwer Academic: The Hague, 1995; 1-24.
2. Niessner M, Volk BA. Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101: 428-435.
3. Allen JE, Maizels RM. Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997; 18: 387-392.
4. Kagi D, Ledermann B, Burki K, et al. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996; 14: 207-232.
5. Shi LF, Mai S, Israels S, et al. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J Exp Med 1997; 185: 855-866.
6. Heusel JW, Wesselschmidt RL, Shresta S, et al. Cytotoxic lymphocytes require granzyme-B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target-cells. Cell 1994; 76: 977-987.
7. Pham CTN, Macivor DM, Hug BA, et al. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA 1996; 93: 13090-13095.
8. Kummer JA, Kamp AM, Tadema TM, et al. Localization and identification of granzyme-A-expressing and granzyme-B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol 1995; 100: 164-172.
9. Chott A, Gerdes D, Spooner A, et al. Intraepithelial lymphocytes in normal human intestine do not express proteins associated with cytolytic function. Am J Pathol 1997; 151: 435-442.
10. McLaughlan JM, Seth R, Vautier G, et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997; 181: 87-92.
11. Muller S, Lory J, Corazza N, et al. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol 1998; 152: 261-268.
12. Kummer JA, Kamp AM, Vankatwijk M, et al. Production and characterization of monoclonal antibodies raised against recombinant human granzyme-A and granzyme-B and showing cross-reactions with the natural proteins. J Immunol Methods 1993; 163: 77-83.
13. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
14. Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology initiative. J Clin Pathol 1997; 50: 93-105.
15. Seth R, Wakatsuki M, Cole A, et al. Are granzyme-B messenger RNA levels raised in inflammatory bowel disease? Gastroenterology 1996; 110: A1013.
16. Savill J. Apoptosis in resolution of inflammation. J Leukocyte Biol 1997; 61: 375-380.
17. McLaughlan J, Jackson L, Robins A, et al. Expression of interleukin-8 and inducible cyclooxygenase enzyme gene activity in pure primary isolates of human gastric epithelial cells. Gut 1997; 41: A146-A147.
18. Zurawski G, Devries JE. Interleukin-13. an interleukin-4 like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol Today 1994; 15: 19-26.
19. Nakajima A, Kodama T, Yazaki Y, et al. Specific clonal T-cell accumulation in intestinal lesions of Crohn's disease. J Immunol 1996; 157: 5683-5688.
20. Gulwani-Akolkar B, Akolkar PN, Minassin A, et al. TCRvbeta-specific alteration of the CD4(+) TCR repertoire in inflamed tissue of Crohn's disease. J Invest Med 1996; 44: A301.
21. Watanabe M, Hayashi A, Hosoda Y, et al. Preferential activation of CD4(+)V-beta-5.2/5.3(+) intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn's disease. Clin Immunol Immunopathol 1996; 78: 130-139.
22. Lugering N, Kucharzik T, Fisahn M, et al. Crohn's disease (CD) patients suffering from peripheral arthritis or ankylosing spondylitis reveal restricted T-cell receptor V-beta regions in different temporal phases of disease. Clin Exp Immunol 1996; 105: 278-284.
23. Qiao L, Golling M, Autschbach F, et al. T-cell receptor repertoire and mitotic responses of lamina propria T-lymphocytes in inflammatory bowel disease. Clin Exp Immunol 1994; 97: 303-308.
24. Bucht A, Soderstrom K, Esin S, et al. Analysis of gamma-delta-V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry. Clin Exp Immunol 1995; 99: 57-64.